Literature DB >> 11774273

Proteomic alterations of the variants of human aldehyde dehydrogenase isozymes correlate with hepatocellular carcinoma.

Kang-Sik Park1, Sang Yun Cho, Hoguen Kim, Young-Ki Paik.   

Abstract

To develop novel markers for hepatocellular carcinomas (HCC), 10 cases were analyzed by 2-dimensional electrophoresis (2DE) and matrix-assisted laser desorption ionization mass spectrometry. Results were compared to those of paired adjacent nontumorous liver tissues. Comparative analysis of the respective spot patterns in 2DE revealed that 3 variants of class 3 aldehyde dehydrogenase (ALDH-3) newly appeared while 2 variants of ALDH-2 diminished to undetectable levels in HCC. However, 4 ALDH-1 variants with different pIs remained unaffected. This pattern of concomitant appearance and disappearance of ALDH-3 and ALDH-2 variants was consistently observed in all HCC tissues. Our results suggest that alterations of ALDH isozyme variants may be closely correlated to HCC and that proteomic analysis of these proteins might be a novel approach to identify the molecular events in detail during hepatocarcinogenesis. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11774273     DOI: 10.1002/ijc.1585

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  21 in total

Review 1.  Mechanisms of MDMA (ecstasy)-induced oxidative stress, mitochondrial dysfunction, and organ damage.

Authors:  Byoung-Joon Song; Kwan-Hoon Moon; Vijay V Upreti; Natalie D Eddington; Insong J Lee
Journal:  Curr Pharm Biotechnol       Date:  2010-08       Impact factor: 2.837

2.  Can proteomics lead to the discovery of real biomarkers for HCC?

Authors:  Yasuhiro Kuramitsu
Journal:  World J Hepatol       Date:  2010-02-27

Review 3.  Glycosylation and liver cancer.

Authors:  Anand Mehta; Harmin Herrera; Timothy Block
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

4.  Genetic ablation of caspase-7 promotes solar-simulated light-induced mouse skin carcinogenesis: the involvement of keratin-17.

Authors:  Mee-Hyun Lee; Do Young Lim; Myoung Ok Kim; Sung-Young Lee; Seung Ho Shin; Jae Young Kim; Sung-Hyun Kim; Dong Joon Kim; Sung Keun Jung; Ke Yao; Joydeb Kumar Kundu; Hye Suk Lee; Cheol-Jung Lee; Sally E Dickinson; David Alberts; G Timothy Bowden; Steven Stratton; Clara Curiel; Janine Einspahr; Ann M Bode; Young-Joon Surh; Yong-Yeon Cho; Zigang Dong
Journal:  Carcinogenesis       Date:  2015-08-12       Impact factor: 4.944

5.  Inactivation of cytosolic aldehyde dehydrogenase via S-nitrosylation in ethanol-exposed rat liver.

Authors:  Kwan-Hoon Moon; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  FEBS Lett       Date:  2007-07-25       Impact factor: 4.124

6.  Proteomics analysis of H-RAS-mediated oncogenic transformation in a genetically defined human ovarian cancer model.

Authors:  Travis Young; Fang Mei; Jinsong Liu; Robert C Bast; Alexander Kurosky; Xiaodong Cheng
Journal:  Oncogene       Date:  2005-09-08       Impact factor: 9.867

7.  Differential liver protein expression during schistosomiasis.

Authors:  Marina Harvie; Thomas William Jordan; Anne Camille La Flamme
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

8.  Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma.

Authors:  Kok Sun Looi; Ernesto S Nakayasu; Raquel A de Diaz; Eng M Tan; Igor C Almeida; Jian-Ying Zhang
Journal:  J Proteome Res       Date:  2008-08-02       Impact factor: 4.466

9.  Identification and characterization of genes involved in embryonic crystal cell formation during Drosophila hematopoiesis.

Authors:  Allison B Milchanowski; Amy L Henkenius; Maya Narayanan; Volker Hartenstein; Utpal Banerjee
Journal:  Genetics       Date:  2004-09       Impact factor: 4.562

10.  Inhibition of hepatic mitochondrial aldehyde dehydrogenase by carbon tetrachloride through JNK-mediated phosphorylation.

Authors:  Kwan-Hoon Moon; Young-Mi Lee; Byoung-Joon Song
Journal:  Free Radic Biol Med       Date:  2009-11-14       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.